Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Effects of resmetirom on metabolic-dysfunction associated steatohepatitis in patients with weight loss and/or diabetes taking glucagon-like peptide-1 receptor agonists and other diabetes therapies: a secondary analysis of the MAESTRO-NASH trial
Initially developed by Novo Nordisk in the 1990s, Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) selective agonist of the GHS-R1a receptor (ghrelin receptor), responsible for stimulating pulsatile growth hormone secretion without the cross-side effects characteristic of non-selective GHRPs
10.1080/0886022X.2020.1719847 Ren Fail
2011 Mar;11(1):1-9
US$ 23.04
US$ 22.80
US$ 22.70
US$ 28.03
US$ 29.91
US$ 25.74
US$ 23.02
US$ 22.27
US$ 27.04
US$ 25.20
US$ 29.00
US$ 21.50
US$ 24.60
US$ 23.18
